A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome
Condition:   Angelman Syndrome Intervention:   Drug: GTX-102 Sponsors:   GeneTx Biotherapeuics, LLC.;   Ultragenyx Pharmaceutical Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2020 Category: Research Source Type: clinical trials

A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome
Condition:   Angelman Syndrome Intervention:   Drug: GTX-102 Sponsors:   GeneTX Biotherapeutics, LLC;   Ultragenyx Pharmaceutical Inc Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 6, 2020 Category: Research Source Type: clinical trials